C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics Stock Forecast

Stock Price Forecast

According to 4 professional analysts, the 12-month price target for C4 Therapeutics stock ranges from a low of $6.00 to a high of $10. The average analyst price target of $8.50 forecasts a 218.35% increase in the stock price over the next year.

Price Target: $8.50 (+218.35%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$8.50	$10	$10
Change	+124.72%	+218.35%	+274.53%	+274.53%

* Price targets were last updated on Sep 23, 2025.

Analyst Ratings

The average analyst rating for C4 Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	1	1	1	1	1	2
Buy	2	2	3	3	3	3
Hold	3	3	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	4	4	4	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tyler Van Buren TD Cowen	TD Cowen	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Dec 2, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $5 → $10	Buy	Maintains	$5 → $10	+274.53%	Sep 23, 2025
Etzer Darout Barclays	Barclays	Buy Maintains $8 → $10	Buy	Maintains	$8 → $10	+274.53%	Sep 23, 2025
Sudan Loganathan Stephens & Co.	Stephens & Co.	Buy Reiterates $6	Buy	Reiterates	$6	+124.72%	Sep 22, 2025
Etzer Darout Barclays	Barclays	Buy Initiates $8	Buy	Initiates	$8	+199.63%	Sep 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

32.83M

Decreased by -7.73%

from 35.58M

Revenue Next Year

22.03M

Decreased by -32.90%

from 32.83M

EPS This Year

-1.56

from -1.52

EPS Next Year

-1.44

from -1.56

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	33.20M	45.79M	31.10M	20.76M	35.58M	32.83M	22.03M
Revenue Growth	55.25%	37.93%	-32.08%	-33.25%	71.44%	-7.73%	-32.90%
EPS	-5.83	-1.82	-2.62	-2.67	-1.52	-1.56	-1.44
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	37.8M	42.0M
Avg	32.8M	22.0M
Low	27.4M	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	6.2%	27.9%
Avg	-7.7%	-32.9%
Low	-22.9%	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-1.26	-0.89
Avg	-1.56	-1.44
Low	-1.95	-2.55

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.